Cover Image
Market Research Report

South and Central America Genomics Market to 2027 - Regional Analysis and Forecasts By Technology (NGS, Sanger Sequencing, Microarray, PCR, Multiplex Ligation-dependent Probe Amplification, and Other Technologies); Application ; End User and Country

Published by The Insight Partners Product code 918694
Published Content info 141 Pages
Delivery time: 1-2 business days
Price
Back to Top
South and Central America Genomics Market to 2027 - Regional Analysis and Forecasts By Technology (NGS, Sanger Sequencing, Microarray, PCR, Multiplex Ligation-dependent Probe Amplification, and Other Technologies); Application ; End User and Country
Published: November 18, 2019 Content info: 141 Pages
Description

The South and Central America genomics market is expected to reach US$ 1,263.61 Mn in 2027 from US$ 527.94 Mn in 2018. The market is estimated to grow with a CAGR of 10.4% from 2019-2027.

The growth of the genomics market is primarily attributed growth in technology developments in genomics rising investments & funds for genomics and development in the field of the agriculture and biotechnology. However, the market is likely to get impacted due to nonexistence of skilled professionals and high cost of equipment used in genomics are likely to pose a negative impact on the market growth. On the other hand, extensive use of genomics for medical applications is likely to have a positive impact on the growth of the South and Central America genomics market in the coming years.

Genomics is the field of science which deals in the production of whole genomes of organisms, and includes elements from genetics. Genomics uses a mixture of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. The large-scale Genome Centers will present the All of Us genomics platform. The genomics platform comprise achieving up to 200,000 genome-wide assays per year, generating high-quality genotyping and genome sequence data, and contributing to the advancement of technologies for population-scale genome analysis. Moreover, World Health Organization (WHO) to initiate almost US $1 million to launch the special program for research and Training in Tropical Diseases (TDR), which was the first broad genomic initiative involving Latin American countries. Thus, a good investments made by the government, companies is expected to increase the growth of the genomics market over the forecast years.

In 2018, the microarray segment held the largest market share in the genomics market, by technology. The microarray is expected to dominate its market share in 2027 owing to the microarrays have been widely used as single-nucleotide-polymorphism (SNP) genotyping platforms and the higher acceptance of the microarray in the field of genomics and wider applications. The next generation sequencing (NGS) segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

Research centers segment held the largest market share in the genomics market, by end user channel in 2018. This segment is also expected to dominate the market in 2027 owing research centers have developed various technologies in the field of the genomics and research centers provides researchers with references for further researches and this factor is likely to increase the market in the forecast period. Hospitals and clinics segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for genomic included in the report are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins., Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, QIAGEN, Eurofins Scientific.Novo Nordisk a/s and others.

Reasons to Buy

Save and reduce time carrying out entrylevel research by identifying the growth, size, leading players and segments in the South and Central America genomics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in South and Central America Genomics Market, thereby allowing players across the value chain to develop effective longterm strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize indepth South and Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decisionmaking process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00007348

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Genomics Market - By Technology
    • 1.3.2 Genomics Market - By Application
    • 1.3.3 Genomics Market - By End User
    • 1.3.4 Genomics Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Genomics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis
  • 4.3 Expert Opinions

5. Genomic Market - Key Industry Dynamics

  • 5.1 Key Drivers
    • 5.1.1 Growth in Investments & Funds for Genomics
    • 5.1.2 Declining Cost of Sequencing Procedures
    • 5.1.3 Technological Developments in Genomics
  • 5.2 Key Restraints
    • 5.2.1 Nonexistence of Skilled Professionals
    • 5.2.2 High Cost of Equipment Used in Genomics
  • 5.3 Key Opportunities
    • 5.3.1 Scopes for the Consumer Genomics
    • 5.3.2 Extensive Use of Genomics for Medical Applications
  • 5.4 Future Trends
    • 5.4.1 Technologies of Genomics
  • 5.5 Impact Analysis

6. Genomics Market - Global Market Analysis

  • 6.1 Global Genomics Market Revenue Forecasts And Analysis

7. Genomics Market -South and Central America Analysis

  • 7.1 South and Central America Genomics Market Revenue Forecasts And Analysis

8. Genomics Market Analysis- By Technology

  • 8.1 Overview
  • 8.2 Genomics Market, By Technology 2018 & 2027 (%)
  • 8.3 Next Generation Sequencing (NGS) Market
    • 8.3.1 Overview
    • 8.3.2 Next Generation Sequencing (NGS) Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Sanger Sequencing Market
    • 8.4.1 Overview
    • 8.4.2 Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Microarray Market
    • 8.5.1 Overview
    • 8.5.2 Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Polymerase Chain Reaction (PCR) Market
    • 8.6.1 Overview
    • 8.6.2 Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 Multiplex Ligation-dependent Probe Amplification (MLPA) Market
    • 8.7.1 Overview
    • 8.7.2 Multiplex Ligation-dependent Probe Amplification (MLPA) Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.8 Other Technologies Market
    • 8.8.1 Overview
    • 8.8.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Genomics Market Analysis- By Application

  • 9.1 Overview
  • 9.2 Genomics Market, By Application 2018 & 2027 (%)
  • 9.3 Diagnostics Market
    • 9.3.1 Overview
    • 9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.3 Cardiogenetics Market
      • 9.3.3.1 Overview
      • 9.3.3.2 Cardiogenetics Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.4 Oncology Market
      • 9.3.4.1 Overview
      • 9.3.4.2 Oncology Market Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.4.3 Oncogenetics Market
        • 9.3.4.3.1 Overview
        • 9.3.4.3.2 Oncogenetics Market Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.4.4 OncoHemato Market
        • 9.3.4.4.1 Overview
        • 9.3.4.4.2 OncoHemato Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.5 Reproductive Disorders Market
      • 9.3.5.1 Overview
      • 9.3.5.2 Reproductive Disorders Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.6 Rare Diseases Market
      • 9.3.6.1 Overview
      • 9.3.6.2 Rare Diseases Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.7 Neurogenetics Market
      • 9.3.7.1 Overview
      • 9.3.7.2 Neurogenetics Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.8 Direct-to-Consumer Market
      • 9.3.8.1 Overview
      • 9.3.8.2 Direct-to-Consumer Market Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.9 Others Market
      • 9.3.9.1 Overview
      • 9.3.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Drug Discovery & Development Market
    • 9.4.1 Overview
    • 9.4.2 Drug Discovery & Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Precision/Personalized Medicine Market
    • 9.5.1 Overview
    • 9.5.2 Precision/Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.6 Animal Research Market
    • 9.6.1 Overview
    • 9.6.2 Animal Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.7 Agriculture Research Market
    • 9.7.1 Overview
    • 9.7.2 Agriculture Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.8 Others Market
    • 9.8.1 Overview
    • 9.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Genomics Market Analysis- By End User

  • 10.1 Overview
  • 10.2 Genomics Market, By End User 2018 & 2027 (%)
  • 10.3 Research Centers Market
    • 10.3.1 Overview
    • 10.3.2 Research Centers Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.4 Hospitals & Clinics Market
    • 10.4.1 Overview
    • 10.4.2 Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.5 Pharmaceutical & Biotechnology Companies Market
    • 10.5.1 Overview
    • 10.5.2 Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.6 Others Market
    • 10.6.1 Overview
    • 10.6.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

11. South And Central America Genomics Market Revenue And Forecasts To 2027

    • 11.1.1 South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.1.2 South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
    • 11.1.3 South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
      • 11.1.3.1 South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
        • 11.1.3.1.1 South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 11.1.4 South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 11.1.5 South and Central America Genomics Market Revenue and Forecasts to 2027, By Country (%)
    • 11.1.6 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.6.1 Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.6.2 Brazil Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
      • 11.1.6.3 Brazil Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
        • 11.1.6.3.1 Brazil Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
        • 11.1.6.3.1.1 Brazil Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 11.1.6.4 Brazil Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 11.1.7 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.7.1 Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.7.2 Argentina Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
      • 11.1.7.3 Argentina Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
        • 11.1.7.3.1 Argentina Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
        • 11.1.7.3.1.1 Argentina Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 11.1.7.4 Argentina Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 11.1.8 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.1 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.2 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
      • 11.1.8.3 Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
        • 11.1.8.3.1 Rest of South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
        • 11.1.8.3.1.1 Rest of South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 11.1.8.4 Rest of South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12. Genomics Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies done by the companies in the Market, 2018 (%)
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
    • 12.3.2 Product Launch
    • 12.3.3 Approvals
    • 12.3.4 Expansion
    • 12.3.5 Product Expansion
    • 12.3.6 Others
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview
    • 12.4.2 Partnership
    • 12.4.3 Acquisition
    • 12.4.4 Collaboration
    • 12.4.5 Agreement

13. Genomics Market-Key Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Agilent Technologies, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Overview
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Danaher
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Information
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Beijing Genomics Institute
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product Portfolio
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Mendelics Genomic Analysis SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Biosystems S.A.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Overview
    • 13.6.4 Product Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Illumina, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Thermofisher Scientific Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Overview
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 QIAGEN
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Overview
    • 13.9.4 Product Portfolio
    • 13.9.5 Swot Analysis
    • 13.9.6 Key Developments
  • 13.10 Eurofins Scientific
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 Product/ Services Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 THE IDENGENE
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Financial Information
    • 13.11.4 Product Portfolio
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Argentine Bioinformatics platform (BIA)
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Financial Overview
    • 13.12.4 Product Portfolio
    • 13.12.5 Swot Analysis
    • 13.12.6 Key Developments
  • 13.13 DLE
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Financial Overview
    • 13.13.4 Product Portfolio
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 DASA
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Financial Overview
    • 13.14.4 Product Portfolio
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Fleury Genomica
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Financial Overview
    • 13.15.4 Product Portfolio
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary Of Terms

LIST OF TABLES

  • Table 1. Price of Various NGS Machines of some Major Players
  • Table 2. South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
  • Table 3. South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • Table 4. South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
  • Table 5. South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • Table 6. South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 7. Brazil Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
  • Table 8. Brazil Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • Table 9. Brazil Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
  • Table 10. Brazil Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • Table 11. Brazil Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 12. Argentina Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
  • Table 13. Argentina Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • Table 14. Argentina Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
  • Table 15. Argentina Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • Table 16. Argentina Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 17. Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
  • Table 18. Rest of South and Central America Genomics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • Table 19. Rest of South and Central America Diagnostic Market Revenue and Forecasts To 2027, By Diseases (US$ Mn)
  • Table 20. Rest of South and Central America Oncology Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • Table 21. Rest of South and Central America Genomics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 22. Recent Product Launch In The Genomics Market
  • Table 23. Product Approval In The Genomics Market
  • Table 24. Expansion Organic Growth Strategies In The Genomics Market
  • Table 25. Product Expansion Organic Growth Strategies In The Genomics Market
  • Table 26. Others Organic Growth Strategies In The Genomics Market
  • Table 27. Recent Partnership In The Genomics Market
  • Table 28. Recent Acquisition In The Genomics Market
  • Table 29. Recent Collaboration In The Genomics Market
  • Table 30. Recent Agreement In The Genomics Market
  • Table 31. Glossary of Terms, Colorectal Cancer Market

LIST OF FIGURES

  • Figure 1. Genomics Market Segmentation
  • Figure 2. Global Genomics Market Overview
  • Figure 3. Microarray Segment Held Largest Share Of The Test Type Segment In Genomics Market
  • Figure 4. Brazil Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 5. Genomics Market, Industry Landscape
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Genomics Market Impact Analysis Of Driver And Restraints
  • Figure 8. Global Genomics Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 9. South and Central America Genomics Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 10. Genomics Market, by Technology 2018 & 2027 (%)
  • Figure 11. Next Generation Sequencing (NGS) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. Sanger Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 13. Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 15. Multiplex Ligation-dependent Probe Amplification (MLPA) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 16. Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 17. Genomics Market, by Application 2018 & 2027 (%)
  • Figure 18. Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 19. Cardiogenetics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Oncogenetics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. OncoHemato Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Reproductive Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Rare Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Neurogenetics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Direct-to-Consumer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Drug Discovery & Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Precision/Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Animal Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Agriculture Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 32. Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Genomics Market, by End User 2018 & 2027 (%)
  • Figure 34. Research Centers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 36. Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. South and Central America Genomics Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 39. South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. South and Central America Genomics Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 41. Brazil Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. Argentina Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Rest of South and Central America Genomics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. Growth Strategies done by the companies in the Market, 2018 (%)
  • Figure 45. Organic Growth Strategies done by the companies in the Market, 2018 (%)
  • Figure 46. Inorganic Growth Strategies done by the companies in the Market, 2018 (%)
Back to Top